“Association of Serum Ferritin With Metabolic Syndrome, Insulin Resistance, Dyslipidemia, and Abdominal Obesity: A Systematic Review”. 2026. World Journal of Current Medical and Pharmaceutical Research 8 (3): 318-22. https://doi.org/10.37022/wjcmpr.v8i3.477.